Tonix Pharmaceuticals Holding Corpinterview with Dr. Seth Lederman, MD, and CEO Transcript
Tonix Pharmaceuticals mission is to improve health by inventing and developing innovative therapies and vaccines. And with me is CEO, Seth Lederman, to talk about this new, perhaps COVID treatment that you have. This is a humanized murine monoclonal antibody for the treatment and also prevention, right, of COVID. So explain in more detail about that.
Thank you, Jane. Thanks for having me back, we're very excited. We license three monoclonal antibodies from Curia, and we're excited because the existing monoclonal antibodies that were developed to treat COVID, no longer work, they've become obsolete because of the variants. So you may have followed that, for example, President Trump's life was saved by a monoclonal antibody. That was one made by Regeneron. There were two versions by Lilly. There's another version by Vir and co-marketed with GSK. And because of the variants, those four therapeutic antibodies are no longer available because they're no longer
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
